Dying in Dignity. An evaluation of dignity therapy among terminal patients
Completed
- Conditions
- terminale faseNVT
- Registration Number
- NL-OMON35116
- Lead Sponsor
- Vrije Universiteit Medisch Centrum
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 174
Inclusion Criteria
o 18 years of age and older
o able to give informed consent
o only patients who realise that they will be dying soon (e.g., patients in hospices; patients who leave the hospital to die)
o life expectancy of min. 3-4 weeks and max. 6 months (patients)
o informed consent
Exclusion Criteria
o life expectancy shorter than 3-4 weeks (patients)
o who (will) are treated with palliative chemotherapy
o who participate in a fase I-trial
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <p>Primary parameters are:<br /><br>* The effect of dignity therapy on the perceived dignity of terminal patients</p><br>
- Secondary Outcome Measures
Name Time Method <p>Secondary parameters are:<br /><br>* The effect of dignity therapy on suffering, loneliness, quality of life and<br /><br>meaning of life (patients)<br /><br>* The effect of dignity therapy on feelings of depression and the bereavement<br /><br>process (family/freinds)<br /><br>* Feasibility and desirability to implement dignity therapy into the palliative<br /><br>program of hospice/hospital?</p><br>